Y mAbs Therapeutics Stock Price

-0.77 (-7.01%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 556,362
Bid Price 8.00
Ask Price 10.27
News -
Day High 11.54


52 Week Range


Day Low 10.085
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.77 -7.01% 10.22 19:46:51
Open Price Low Price High Price Close Price Prev Close
10.75 10.085 11.54 10.22 10.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,289 556,362 $ 10.47 $ 5,826,280 - 10.085 - 50.70
Last Trade Time Type Quantity Stock Price Currency
16:59:13 formt 280 $ 10.22 USD


Draw Mode:

Y mAbs Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 446.04M 43.64M 34.70M $ 20.75M $ -15.08M -2.97 -11.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 429.39k 1.00%

more financials information »

Y mAbs Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical YMAB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.4212.8010.08511.23522,834-2.20-17.71%
1 Month17.19518.0510.08513.56287,163-6.98-40.56%
3 Months25.5128.49510.08517.11279,247-15.29-59.94%
6 Months32.8639.819910.08523.33231,517-22.64-68.9%
1 Year45.9050.7010.08529.58260,184-35.68-77.73%
3 Years22.6355.3610.08531.90210,757-12.41-54.84%
5 Years26.5055.3610.08531.28204,280-16.28-61.43%

Y mAbs Therapeutics Description

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.

Your Recent History
Y mAbs The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.